Herbs on Alternative Medicine Zone

Who Should Pause Before Taking Ashwagandha? A Safety Reset for the Internet's Favourite Stress Herb

Sun, 14 Jun 2026 12:00:00 -0400

Ashwagandha is having a moment. It’s in the supplement aisle, it’s in the wellness influencer’s morning routine video, and it’s increasingly in the “my doctor actually recommended this” conversation - which, honestly, is a good sign for an herb that’s been used in Ayurvedic medicine for thousands of years. The root of the Withania somnifera plant has been a rasayana - a rejuvenative tonic - for stress, sleep, and vitality since long before randomised controlled trials existed.

And those trials? They’re starting to accumulate. Multiple meta-analyses from 2022 to 2025 have found that ashwagandha root extract, typically at 300–600 mg per day, reduces perceived stress scores, anxiety scores, and serum cortisol compared to placebo over 8–12 weeks. The signal is consistent enough that Mayo Clinic’s Dr. Denise Millstine has described it as a reasonable option for stress relief - with some important caveats (Mayo Clinic Q&A). The meta-analytic evidence backs this up: a 2022 dose-response meta-analysis of 12 trials and 1,002 participants (PubMed), a 2025 BJPsych Open meta-analysis of 15 RCTs (PubMed Central), and a 2025 systematic review (PubMed) all converge on the same basic signal.

But here’s the thing: the safety conversation hasn’t kept up with the popularity. And for certain groups of people, pausing before taking ashwagandha isn’t just prudent - it’s the difference between a useful supplement and a real clinical risk.

This isn’t about whether ashwagandha “works.” It’s about who needs to hit pause before trying it.

Turmeric and Curcumin: Separating the Spice from the Extract

Sun, 14 Jun 2026 00:00:00 +0000

Turmeric is a spice. Curcumin is a compound found in turmeric. Most of what you’ve heard about the health benefits of turmeric is actually about curcumin - and most of what you’ve heard about curcumin comes from studies using doses you can’t get from cooking.

This distinction matters more than most supplement marketing lets on. It’s the difference between a kitchen staple that’s good for you and a concentrated extract with real-but-modest clinical effects. And somewhere between the “miracle spice” headlines and the dismissive “it’s all hype” rebuttals, there’s an actual evidence base worth understanding.

Ashwagandha: What 12 Clinical Trials Actually Found

Sat, 13 Jun 2026 00:00:00 +0000

Ashwagandha (Withania somnifera) is one of the most researched herbs in the Ayurvedic tradition. It’s classified as an adaptogen - a term that gets thrown around a lot but deserves some scrutiny. The clinical research on ashwagandha has grown substantially over the past decade, enough that we can say more than “it might help with stress.” Here’s what the trials actually show.

Green Tea Extract: The Liver Risk Nobody Talks About

Fri, 12 Jun 2026 00:00:00 +0000

Green tea is one of the most consumed beverages on the planet. The epidemiological evidence is solid: people who regularly drink green tea have lower rates of cardiovascular disease and certain cancers in large population studies. But green tea extract - the concentrated form sold in weight-loss pills, energy supplements, and “fat burner” stacks - isn’t green tea. And the difference matters for your liver.